About
Chris is a Venture Partner with Catapult’s GM&C Life Sciences Fund, where he assesses investment opportunities and works with the Fund’s smaller investments to help companies successfully grow, with a particular focus on digital health technologies. Chris was until recently CEO of EMIS Group plc (FTSE listed), the UK leader in healthcare software and solutions across nearly every major healthcare setting – from GP surgeries to high street pharmacies, and hospitals to community services. Chris joined EMIS in 1999 and his roles have included Commercial Development Director, Group Legal Counsel, Chief Administrative Officer and since 2013, CEO. Chris has nearly 40 years’ experience of general management, leadership, law and software/digital development within the healthcare, legal and educational sectors both as a founder of his own companies and a senior manager in established companies. Chris graduated from Leeds University with a LLB in Law.
Position in the VCSift Database
- • 8 investors at Catapult Ventures are tracked.
- • 421 investors hold the Venture Partner role in VCSift. Chris Spencer is one of them.
- • 8,972 investors are based in London, England, United Kingdom.
Data sourced from 410,343 investor profiles. Updated June 2026.
Investment Focus
- Location
- London, UK
Contact Information
Find more investors like Chris
Search Investors